2010 Epilepsy Patients 
Project CBD
MARCH 21, 2023
The CBD she took may or may not have helped, but according to a recent survey of tinnitus patients, she wasn’t alone in trying — or at least in being interested in cannabis as a potential remedy. But many more patients were willing to try, perhaps as an indication of the intractability of chronic tinnitus.
Cannabis Law Report
JANUARY 15, 2019
British firm GW Pharmaceuticals is licking its wounds after US judges tossed out its attempt to patent multiple cannabinoids for epilepsy treatment following an eight-year battle. The patent, which has been embroiled in dispute since 2010, is for “the use of one or more cannabinoids in the treatment of epilepsy”.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
MARCH 19, 2025
Medical marijuana ended up on the ballot once again in 2010, but this initiative also failed at 36% in favor to 63% not in favor. A medical patient could end up in jail for possessing even small amounts of marijuana. If authorized, medical patients can cultivate up to two flowering and two non-flowering cannabis plants.
Greencamp
AUGUST 16, 2018
Because of the very rapid progression of ALS in the majority of patients, understanding how cannabis could help in the alleviation of symptoms is incredibly important for ALS sufferers. Both upper and lower motor neurons suffer severe damage in ALS patients. As few as 10% of ALS patients live longer than 10 years after being diagnosed.
Cannabis Law Report
MAY 9, 2022
The company is following in the footsteps of GW Pharmaceuticals, a trailblazer that developed the first cannabis-based medicine to be licensed in the UK in 2010, Sativex for multiple sclerosis, which costs about £2,000 a year. However, NHS prescribing of the mouth spray remains very limited and varies across the country.
LifeCannMD
JANUARY 2, 2024
Here’s a breakdown of how cannabis might help those with Florida qualifying conditions : Florida Cancer Patients : Patients say that it benefits them in several ways: by quelling nausea, suppressing vomiting resulting from chemotherapy, increasing appetite, alleviating pain, and soothing anxiety.
Cannabis Law Report
JULY 12, 2019
Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Review: During an open-label trial of pure CBD with Lennox-Gastaut and Dravet patients, 79% of all patients reported side effects.
Expert insights. Personalized for you.
144 
Let's personalize your content